BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38449868)

  • 21. Scaffold attachment factor B suppresses HIV-1 infection of CD4
    Ma L; Sun L; Jin X; Xiong SD; Wang JH
    J Biol Chem; 2018 Aug; 293(31):12177-12185. PubMed ID: 29887524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes.
    Coyle-Rink J; Sweet T; Abraham S; Sawaya B; Batuman O; Khalili K; Amini S
    Virology; 2002 Aug; 299(2):240-7. PubMed ID: 12202226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes.
    van der Sluis RM; Derking R; Breidel S; Speijer D; Berkhout B; Jeeninga RE
    J Gen Virol; 2014 Apr; 95(Pt 4):968-979. PubMed ID: 24447950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
    Giacca M; Gutierrez MI; Menzo S; d'Adda di Fagagna F; Falaschi A
    Virology; 1992 Jan; 186(1):133-47. PubMed ID: 1727595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
    Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
    J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Nup98 in transcription regulation in healthy and diseased cells.
    Franks TM; Hetzer MW
    Trends Cell Biol; 2013 Mar; 23(3):112-7. PubMed ID: 23246429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
    Barbeau B; Bernier R; Dumais N; Briand G; Olivier M; Faure R; Posner BI; Tremblay M
    J Biol Chem; 1997 May; 272(20):12968-77. PubMed ID: 9148903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
    Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
    Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
    Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH
    PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshifting.
    Roesmann F; Sertznig H; Klaassen K; Wilhelm A; Heininger D; Heß S; Elsner C; Marschalek R; Santiago ML; Esser S; Sutter K; Dittmer U; Widera M
    J Virol; 2024 Jun; ():e0053424. PubMed ID: 38899932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and purification of a novel transcriptional repressor from HeLa cell nuclear extracts recognizing the negative regulatory element region of human immunodeficiency virus-1 long terminal repeat.
    West M; Mikovits J; Princler G; Liu YL; Ruscetti FW; Kung HF; Raziuddin
    J Biol Chem; 1992 Dec; 267(35):24948-52. PubMed ID: 1459999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complexes of vesicular stomatitis virus matrix protein with host Rae1 and Nup98 involved in inhibition of host transcription.
    Rajani KR; Pettit Kneller EL; McKenzie MO; Horita DA; Chou JW; Lyles DS
    PLoS Pathog; 2012 Sep; 8(9):e1002929. PubMed ID: 23028327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.
    Shah S; Alexaki A; Pirrone V; Dahiya S; Nonnemacher MR; Wigdahl B
    Virol J; 2014 May; 11():92. PubMed ID: 24886416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular specificity of HIV-1 replication can be controlled by LTR sequences.
    Reed-Inderbitzin E; Maury W
    Virology; 2003 Sep; 314(2):680-95. PubMed ID: 14554095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
    Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
    Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.